AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03213314 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Multiparameter magnetic resonance imaging
Description: LiverMultiScan before and after surgery to assess liver health prior to liver resection and in the regenerative phase.
Study NCT03864276 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inhalation (desflurane) group
Description: Anesthesia is induced and maintained with desflurane and sufentanil
Study NCT03864276 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: total intravenous (propofol) anesthesia
Description: Anesthesia is induced and maintained with propofol and sufentanil
Study NCT01249170 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: First year program
Description: Information on group that underwent new educational program
Study NCT03054090 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Quality Improvement Support
Description: Practices will receive a blended strategy of quality improvement facilitation to help participating practices incorporate PCOR clinical and organizational findings while building their overall practice capabilities. Primary care practices will be provided tools and training to improve the rates of screening and treatment of risk factors for heart attacks and strokes, as well as other chronic illnesses and the delivery of preventive services.
Study NCT03620825 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dehydration by sauna exposure
Description: Participants repeatedly undergo sauna exposures until they loose 3% of their body weight.
Study NCT01249170 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control comparison
Description: Information from group that did not undergo new first year program
Study NCT03550248 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Healthy Together
Description: The Healthy Together (HT) program is designed to reduce overweight and obesity among children and youth in priority populations such as Indigenous, immigrant and refugee, and low income families.The HT program consists of 30 sessions, each of which includes cooking and eating together, physical activity and a learning activity covering topics that promote healthy weights. The HT program is delivered by trained facilitators who are provided with a program manual and resources. Trained facilitators in participating community organizations offer the HT program by integrating it within core programming.
Study NCT00522860 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Trichiasis surgery with absorbable sutures
Description: Posterior lamellar tarsal rotation. Vicryl sutures, 5/0, 3/8 curved needle, cutting. Three everting sutures.
Study NCT00522860 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Trichiasis surgery with non-absorbable sutures
Description: Posterior lamellar tarsal rotation. Silk sutures. 4/0. 3/8 curved cutting needle. Three sets of everting sutures.
Study NCT04269551 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIVV020
Description: Pharmaceutical form:solution for injection Route of administration: intravenous
Study NCT00275080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vorinostat
Description: Given orally
Study NCT00275080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: decitabine
Description: Given IV
Study NCT05015387 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Minimally invasive non-surgical therapy
Description: Under local anesthesia subgingival instrumentation with ultrasonic and hand instruments and magnification (4.5x) was performed.
Study NCT05015387 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimally invasive non-surgical therapy
Description: Under local anesthesia subgingival instrumentation with ultrasonic and hand instruments and magnification (4.5x) was performed.
Study NCT05015387 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Subgingival application of collagen hydrogels with proanthocyanidins
Description: Patients received collagen hydrogel chips with proanthocyanidins from Pelargonium sidoides root extract, placed subgingivally in periodontal pockets with PPD≥4mm after minimally invasive non-surgical therapy.
Study NCT05015387 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Collection of saliva samples
Description: For MMP-3/TIMP-1 detection, the collection of saliva samples was performed using Salivette (SARSTEDT AG and Co, Germany) saliva sample collection kit. Saliva samples were collected at the baseline for all patients and 8 weeks after treatment. Samples were centrifuged at 3500 rpm (2 min), aliquoted and protease inhibitors cocktail (1 mg/ml) was added to each sample. All samples were stored at -80oC. MMP-3, TIMP-1 concentration in saliva samples was examined using commercial ELISA kits (Elabscience, USA) and Multiskan Microplate Photometer (Thermo Fisher Scientific) at 450 nm wavelength. Saliva MMP-3/TIMP-1 samples were collected before treatment and 8 weeks after treatment.
Study NCT05015387 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Collection of saliva samples
Description: For MMP-3/TIMP-1 detection, the collection of saliva samples was performed using Salivette (SARSTEDT AG and Co, Germany) saliva sample collection kit. Saliva samples were collected at the baseline for all patients and 8 weeks after treatment. Samples were centrifuged at 3500 rpm (2 min), aliquoted and protease inhibitors cocktail (1 mg/ml) was added to each sample. All samples were stored at -80oC. MMP-3, TIMP-1 concentration in saliva samples was examined using commercial ELISA kits (Elabscience, USA) and Multiskan Microplate Photometer (Thermo Fisher Scientific) at 450 nm wavelength. Saliva MMP-3/TIMP-1 samples were collected before treatment and 8 weeks after treatment.
Study NCT00917384 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ramucirumab
Description: Administered via intravenous infusion every 2 weeks at a dose of 8 mg/kg
Study NCT00917384 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo comparator for ramucirumab 8 mg/kg as intravenous infusion every 2 weeks
Study NCT00917384 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Best Supportive Care (BSC)
Description: BSC as determined appropriate by the investigator(s). BSC may include but are not limited to antiemetic agents, opiate and nonopiate analgesic agents, appetite stimulants, and granulocyte and erythroid growth factors.
Study NCT00917384 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Best Supportive Care (BSC)
Description: BSC as determined appropriate by the investigator(s). BSC may include but are not limited to antiemetic agents, opiate and nonopiate analgesic agents, appetite stimulants, and granulocyte and erythroid growth factors.
Study NCT01449838 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colistimethate sodium
Description: active
Study NCT01449838 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: placebo
Study NCT02372617 — intervention group
Intervention type: PROCEDURE
Intervention: periacetabular osteotomy
Study NCT03840629 — intervention group
Intervention type: OTHER
Intervention: No study intervention.
Study NCT02406664 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Description: Laparoscopic or Robot R-Y gastric bypass
Study NCT02636309 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: physical therapy at work
Description: gymnastcis, exercise orientation, ergonomics, acupuncture at work setting
Study NCT02081963 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amikacin
Description: Nebulized 0.2g of amikacin and 2 mL of normal saline twice a day for 14 days in combination with standard treatment.
Study NCT02081963 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Normal saline
Description: Nebulized 3 mL of normal saline twice a day for 14 days in combination with standard treatment.
Study NCT03620825 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Indomethacin
Description: Participants take indomethacin in tablet form the evening before and the morning of the visit to induce intestinal permeability
Study NCT02399436 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: School-Based Healthy Snacking Campaign
Description: The school-based healthy snacking campaign includes the following activities:~* Sales promotion of snack choices that meet federal Smart Snack guidelines during the school day and at school events, such as snack bars and after-school events;~* The installation of new filtered water fountains outfitted with water-filling stations;~* The distribution of re-usable water bottles to students at participating schools; and~* A social marketing campaign to support adoption of the healthy snacks and water consumption by students.
Study NCT02399436 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Cooking Classes
Description: Cooking classes will be delivered to groups of 8-12 adult participants as a series of 8 weekly classes in community venues. The content of each class is driven by topics and themes identified and prioritized by community members, namely cooking healthy on tight budget.
Study NCT02794610 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Description: Topical tacrolimus 0.05% eye drops will be instilled into the eyes of patients every minute for 5 minutes. After 15 minutes, at the time of cataract surgery, aqueous samples will be collected and will be subjected to detection of presence and level of tacrolimus.
Study NCT03045510 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: decitabine
Description: Decitabine 3.5mg/m2，ivdrip，qd x 5d, every four weeks for one cycle. It will be given six cycles.
Study NCT04576377 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: FluBlok
Description: Recombinant HA quadrivalent influenza vaccine (0.5mL Flublok®, Sanofi Pasteur) containing 180μg antigen, 45μg for each influenza strain included.
Study NCT04576377 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.5mL saline placebo.
Study NCT03923920 — intervention group
Intervention type: PROCEDURE
Intervention: Biopsy
Description: During clinically-scheduled spinal stenosis surgery, ligamentum flavum tissue (which may contain surrounding tissue and subcutaneous fat) that is removed during the procedure will be sent to pathology to be analyzed with amyloid-specific staining.
Study NCT01901562 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ductoscopic papillectomy
Description: Intraductal papilloma extraction through the nipple orifice by interventional ductoscopy
Study NCT03086031 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Program -based vocational rehabilitation intervention
Description: The VR intervention lasts for a total of 6-9 months with first six different modules (3-month) that are individually planned, and second a work placement program (approximately 3-6 months). Each of the different modules follows a comprehensive standard operating procedures (SOP's). The six modules will be grouped into (a) individual therapies which includes neuropsychological sessions (10-hours), balance between work and everyday life (20-hours), and job matching (10-hours), (b) grouped-based therapies which includes psycho education (18-hours), mindfulness (15-hours), and physiotherapy training (15-hours), (c) an manualized family intervention program (8 sessions of 90 minutes), and an individual caregiver coaching (12-hours), (d) a work placement program including work practice (3-6 month), supported employment by the rehabilitation team (30-hours), and the development of a post rehabilitation plan (4-hours).
Study NCT03086031 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional vocational rehabilitation (controls)
Description: Treatment as usual delivered by the municipalities.
Study NCT01463332 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: I.V injection of 10 ml normal saline
Description: Patients were randomly assigned in to three groups of 50 each using a computer-generated table of random numbers. Patients Group NS were injected intravenously with 10 ml of normal saline before injection of propofol.
Study NCT00369759 — intervention group
Intervention type: OTHER
Intervention: Emergency Dept. Subjects with LRI or Apnea
Description: No intervention; Epidemiological Study
Study NCT01463332 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: I.V injection with 0.25mic/kg of dexmedetomidine
Description: Patients were randomly assigned in to three groups of 50 each using a computer-generated table of random numbers. Patients Group D25 were injected intravenously with 0.25mic/kg of dexmedetomidine diluted with normal saline into 10ml before injection of propofol.
Study NCT01463332 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: I.V injection of 0.50mic/kg of dexmedetomidine
Description: Patients were randomly assigned in to three groups of 50 each using a computer-generated table of random numbers. Patients Group D50 were injected intravenously with 0.50mic/kg of dexmedetomidine diluted with normal saline into 10ml before injection of propofol.
Study NCT00518245 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: enoxaparin
Description: Enoxaparin will be given subcutanteously at a dose of 1mg/kg every 12 hours for a minimum of 48 hours (4 doses) and a maximum of 8 days until a diagnostic / therapeutic procedure is performed, or at the discretion of the investigator.
Study NCT04174040 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Gross's Process of Emotion Regulation Model Interventions
Description: Interventions were based on Gross's Process Model which include the basis concepts of cognitive-behavioral therapy and carried on with five semi-structured sessions. Cognitive-behavioral theories accept the existence of a thought process (attention-perception-interpretation) that appears in the mind about the event just before the anger emerges. Therefore, anger studies with cognitive-behavioral approach generally proceed with the steps of gaining awareness about this concealed thought, identifying behavioral response and avoidance attitudes and thus regulating emotion. It consists of five 90-minute group sessions structured in this context. While being an accredited cognitive behavioral therapist, investigator have qualified to manage these approach.~The effectiveness of these semi-structured sessions were evaluated by using:~1. Pretest application of STAXI~2. Taking feedback after each intervention session~3. Posttest application of STAXI~4. Follow-up test application of STAXI
Study NCT04174040 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gross's Process of Emotion Regulation Model Interventions
Description: Interventions were based on Gross's Process Model which include the basis concepts of cognitive-behavioral therapy and carried on with five semi-structured sessions. Cognitive-behavioral theories accept the existence of a thought process (attention-perception-interpretation) that appears in the mind about the event just before the anger emerges. Therefore, anger studies with cognitive-behavioral approach generally proceed with the steps of gaining awareness about this concealed thought, identifying behavioral response and avoidance attitudes and thus regulating emotion. It consists of five 90-minute group sessions structured in this context. While being an accredited cognitive behavioral therapist, investigator have qualified to manage these approach.~The effectiveness of these semi-structured sessions were evaluated by using:~1. Pretest application of STAXI~2. Taking feedback after each intervention session~3. Posttest application of STAXI~4. Follow-up test application of STAXI
Study NCT04174040 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Musical Rhythm Interventions
Description: This musical group rhythm intervention was continued with 90 minute long five sessions. The students participated in the practice together with a music expert and lead researcher. The lead researcher took on the role of observer in these sessions. Each session was continued with warming, improvisation and targeted semi-structured rhythm practices aiming anger regulation. The effectiveness of these semi-structured sessions were evaluated by using:~1. Pretest application of STAXI~2. Taking feedback after each intervention session~3. Posttest application of STAXI~4. Follow-up test application of STAXI
Study NCT04174040 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Musical Rhythm Interventions
Description: This musical group rhythm intervention was continued with 90 minute long five sessions. The students participated in the practice together with a music expert and lead researcher. The lead researcher took on the role of observer in these sessions. Each session was continued with warming, improvisation and targeted semi-structured rhythm practices aiming anger regulation. The effectiveness of these semi-structured sessions were evaluated by using:~1. Pretest application of STAXI~2. Taking feedback after each intervention session~3. Posttest application of STAXI~4. Follow-up test application of STAXI
Study NCT04174040 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Musical Rhythm Integrated Gross's Emotion Regulation Process Interventions
Description: The students participated in the practice together with a music expert and lead researcher. The lead researcher ensured the integration of rhythm applications into the Process Model through cognitive-behavioral semi-structured interventions. Five semi-structured 90-minute group sessions were performed. The effectiveness of the experiment was evaluated by using:~1. Pretest application of STAXI~2. Taking feedback after each intervention session~3. Posttest application of STAXI~4. Follow-up test application of STAXI
Study NCT00943553 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: decitabine Induction Chemotherapy
Description: Arm A - 12 days (5 days of intravenous (IV) decitabine 20 mg/m\^2 followed by 7 days of induction chemotherapy with IV daunorubicin 45 mg/m\^2 and cytarabine 100 mg/m\^2/day)
Study NCT00943553 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Induction Chemotherapy
Description: Arm B - 7 days (7 days of induction chemotherapy with IV daunorubicin 45 mg/m\^2 and cytarabine 100 mg/m\^2/day only)
Study NCT05157919 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ICU-Care
Description: The mobile app intervention, ICU-CARE, will consist of 3 separate education modules, each approximately 5-7 minutes in length: (Module #1) ICU orientation, (Module #2) Symptom Assessment, (Module #3) Symptom Management
Study NCT03687905 — intervention group
Intervention type: DRUG
Intervention: Chloroquine
Description: group1 received chloroquine .
Study NCT03687905 — intervention group
Intervention type: DRUG
Intervention: Hydroxychloroquine
Description: Group 2 received hydroxychloroquine
Study NCT01385332 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Early luteal phase
Description: We will administer in the tenth day of the cycle 0.25mg/day of ganirelix until the estradiol levels will be less than 60pgr/mL. Then, we'll start a standard protocol of controlled ovarian hyperstimulation beginning with 150 UI/day. At 6th day of stimulation we'll begin with the antagonist.
Study NCT01385332 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Late follicular phase -COH-
Description: We will administer in the 20th day of the cycle 0.25mg/day of ganirelix until the estradiol levels will be less than 60pgr/mL. Then, we'll start a standard protocol of controlled ovarian hyperstimulation beginning with 150 UI/day. At 6th day of stimulation we'll begin with the antagonist.
Study NCT01698138 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Onabotulinumtoxin A
Description: 30 transurethral injections, each of 1 ml solution containing 300 U Onabotulinumtoxin A (Botox ®, Allergan) in 30 ml of NaCl 0.9 %.
Study NCT01698138 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 30 transurethral injections, each of 1 ml solution containing NaCl.
Study NCT03299179 — intervention group
Intervention type: DEVICE
Intervention: MRI scan
Description: Several MRI scan modalities: MPRAGE (structural scan), arterial spin labeling (cerebral perfusion), resting state functional-MRI (fMRI, cerebral activity) and diffusion MRI (white matter diffusion and white matter tracts).
Study NCT03299179 — intervention group
Intervention type: DEVICE
Intervention: Physiological monitoring
Description: During MRI: heart rate, end-tidal carbon dioxide (CO2), respiratory rate and skin conductance
Study NCT06308861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Single administration Bmg dose Group
Description: Orally, Bmg tablet single administration
Study NCT06308861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Single administration Cmg dose Group
Description: Orally, Cmg tablet single administration
Study NCT03299179 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood sample
Description: Blood sample after MRI-session: measurement of hematocrit, hemoglobin, estradiol, progesterone, follicle stimulation hormone and luteinizing hormone.
Study NCT03299179 — intervention group
Intervention type: DEVICE
Intervention: Blood pressure measurement
Description: Measuring blood pressure before and after MRI-scan
Study NCT03299179 — intervention group
Intervention type: DEVICE
Intervention: Body temperature
Description: Measuring body temperature before and after MRI-scan
Study NCT03299179 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: Questionnaires at the start of the study on lifestyle. Additionally, a questionnaire before each scan session on the actual state of the volunteer (e.g. mood, caffeine consumption, alcohol, medication, etc.)
Study NCT03299179 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Pregnancy test
Description: Test for pregnancy using a pregnancy dipstick test
Study NCT03473028 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: transabdominal ultrasound guided embryo transfer
Description: 400 female with body mass index more than 30undergo transabdominal ultrasound guided embryo transfer